Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows

With the introduction of direct-acting antiviral agents (DAA), the rate of sustained virological response (SVR) in the treatment of hepatitis C virus (HCV) has radically improved to over 95%. Robust scientific evidence supports a beneficial role of SVR after interferon therapy in the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarino, Maria, Sessa, Anna, Cossiga, Valentina, Morando, Federica, Caporaso, Nicola, Morisco, Filomena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021774/
https://www.ncbi.nlm.nih.gov/pubmed/29962815
http://dx.doi.org/10.3748/wjg.v24.i24.2582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021774/
https://www.ncbi.nlm.nih.gov/pubmed/29962815
http://dx.doi.org/10.3748/wjg.v24.i24.2582

Ejemplares similares